Triferic (Rockwell Medical, Inc)
Welcome to the PulseAid listing for the Triferic drug offered from Rockwell Medical, Inc. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rockwell Medical, Inc |
NON-PROPRIETARY NAME: | Ferric Pyrophosphate Citrate |
SUBSTANCE NAME: | FERRIC PYROPHOSPHATE CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | HEMODIALYSIS; PARENTERAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-09-04 |
END MARKETING DATE: | 0000-00-00 |
Triferic HUMAN PRESCRIPTION DRUG Details:
Item Description | Triferic from Rockwell Medical, Inc |
LABELER NAME: | Rockwell Medical, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 272(mg/50mL) |
START MARKETING DATE: | 2015-09-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57278-316_5b5dcf9d-071d-6aa4-e053-2991aa0afa32 |
PRODUCT NDC: | 57278-316 |
APPLICATION NUMBER: | NDA206317 |
Other FERRIC PYROPHOSPHATE CITRATE Pharmaceutical Manufacturers / Labelers: